![](https://thelimbic.com/wordpress/wp-content/uploads/2024/01/Prof-Barbora-De-Courten.jpeg)
Distinguished Professor Barbora de Courten
Australia Day Honours typically celebrate the past achievements and service of recipients but for Distinguished Professor Barbora de Courten, her OAM is motivation to do even more.
Professor de Courten, Associate Dean and Professor of Medicine at RMIT University and an Adjunct Professor at Monash University and University of Queensland and Specialist Physician at Monash Health, was awarded the Medal of the Order of Australia in the General Division for her service to medical research, and to healthcare.
She told the limbic she was very honoured to be recognised, particularly as someone who wasn’t born in Australia.
“Being recognised through an Order of Australia is a significant acknowledgement but the question is, what can you then do with that for the greater good of society and the medfical profession. This sort of award gives you recognition but also agency to do more.”
Professor de Courten, who has a broad background across epidemiology, pathophysiology, clinical trials and public health, said her seminal research was her early work conducted in the US identifying inflammation as a predictor of insulin resistance and later development of type 2 diabetes. [link here]
In her 20 years in Australia, her research has included identifying novel predictors of chronic diseases and nutritional and drug therapies that lower chronic inflammation and can be used for the prevention and treatment of obesity, type 2 diabetes, and cardiovascular disease.
She has led the Healthy Ageing Program at Monash University (2020-2022) and before then was Head of Clinical Endocrinology and Metabolism at the Baker Heart and Diabetes Institute (2004-2015).
On her list to “do more” to create a larger impact in healthcare is a plan to establish a multidisciplinary Centre for Health by Design at RMIT University.
She said co-design in healthcare was often tokenistic – with solutions often presented to consumers and other stakeholders as a fait accompli except for some superficial fine tuning.
Instead, “design thinking” to address healthcare problems will truly put the perspectives of users – patients or clinicians – at the centre and through this redefine the issues and reveal novel solutions.
“So for example, in our diabetes clinics at Monash Health, we have a relatively big proportion of people who do not present to their medical appointments despite getting a SMS a few days prior to the appointment.”
“One obvious solution could be to send patients more reminders but if you actually start with the patient, empathise with them and understand their journey through the healthcare system, you may find out that the problem lies somewhere else like transport to the hospital.
“A lot of our patients at Monash Health have low socioeconomic status and language barriers. Therefore the solution in this case might be providing transport or telehealth.”